5,405 Shares in National Research Co. (NASDAQ:NRC) Acquired by SG Americas Securities LLC

SG Americas Securities LLC bought a new position in shares of National Research Co. (NASDAQ:NRC) during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 5,405 shares of the company’s stock, valued at approximately $124,000.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Precision Wealth Strategies LLC increased its holdings in shares of National Research by 7.9% in the 1st quarter. Precision Wealth Strategies LLC now owns 5,623 shares of the company’s stock worth $223,000 after buying an additional 413 shares during the last quarter. Russell Investments Group Ltd. increased its holdings in shares of National Research by 6.3% in the 1st quarter. Russell Investments Group Ltd. now owns 14,348 shares of the company’s stock worth $568,000 after buying an additional 847 shares during the last quarter. Rhumbline Advisers increased its holdings in shares of National Research by 4.3% in the 2nd quarter. Rhumbline Advisers now owns 21,453 shares of the company’s stock worth $492,000 after buying an additional 892 shares during the last quarter. CWM LLC increased its holdings in shares of National Research by 889.7% in the 2nd quarter. CWM LLC now owns 1,158 shares of the company’s stock worth $27,000 after buying an additional 1,041 shares during the last quarter. Finally, Benjamin F. Edwards & Company Inc. grew its holdings in shares of National Research by 145.6% during the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 2,783 shares of the company’s stock valued at $64,000 after purchasing an additional 1,650 shares during the last quarter. Institutional investors own 47.26% of the company’s stock.

National Research Price Performance

NRC stock opened at $17.96 on Friday. The company has a debt-to-equity ratio of 0.64, a quick ratio of 0.37 and a current ratio of 0.37. National Research Co. has a 52 week low of $17.78 and a 52 week high of $43.98. The firm’s fifty day moving average is $20.95 and its 200 day moving average is $25.16. The firm has a market cap of $428.83 million, a P/E ratio of 14.48 and a beta of 0.49.

National Research (NASDAQ:NRC) last released its earnings results on Tuesday, August 6th. The company reported $0.26 EPS for the quarter. National Research had a net margin of 20.01% and a return on equity of 63.64%. The company had revenue of $35.02 million for the quarter.

National Research Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, October 11th. Investors of record on Friday, September 27th were issued a dividend of $0.12 per share. This represents a $0.48 annualized dividend and a dividend yield of 2.67%. The ex-dividend date was Friday, September 27th. National Research’s dividend payout ratio is currently 38.71%.

National Research Company Profile

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.